Risk Assessment for On-Site Inspections

Recommendation
11-13 November 2025
Vienna, Austria
An advanced Auditor Course with many interactive Sessions and practical Examples
Due to the pandemic-related travel restrictions, supervising authorities are currently mostly carrying out so-called distant assessments. However, most inspectorates also carry out partial on-site inspections, sometimes even unannounced.
The PIC/S has now developed a "Covid-19 Risk Assessment for National Routine On-Site Inspections". This risk assessment is based on a FMEA (Failure Mode and Effects Analysis) and should be carried out during the planning phase of the inspection together with the company to be inspected.
Topics to be discussed and assessed include:
- Limitation of possible COVID-19 exposure for inspectors
- Clothing (e.g. it is recommended to take off jewellery and to wear waterproof shoes)
- Cleaning of the workplace and materials used
- National guidelines for face coverings
- General hygiene guidelines
But what about unannounced inspections?
If an unannounced inspection has to take place, an "individual bespoke risk assessment" should be carried out; the assessment suggested in the document should then not be used.
Related GMP News
14.10.2025Two new GDP Non-Compliance Reports from Romania
01.10.2025Alternative Inspection Methods of the FDA
24.09.2025FDA issues final Guidance on Remote Oversight Tools
24.09.2025Four Warning Letter concerning CAPA and Root Cause Analysis published
03.09.2025FDA Report on the State of Pharmaceutical Quality
27.08.2025Bizarre Findings in FDA Warning Letters